PetIQ, Inc. (PETQ) Misses Q3 EPS, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
PetIQ, Inc. Reports Third Quarter 2018 Financial Results
November 13, 2018 4:05 PM ESTThird Quarter Net Sales Increase 117% Year-Over-Year to $131.4 Million Raises Full Year 2018 Net Sales Outlook to Approximately $515 Million
EAGLE, Idaho, Nov. 13, 2018 (GLOBE NEWSWIRE) -- PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the three and nine months ended September 30, 2018.
Third Quarter 2018 Highlights Compared to Prior Year Period
Record third quarter net sales of $131.4 million, an increase of 117%Net income of $3.9 million compared to $0.9 millionAdjusted EBITDA of... More